HomeCompareDNVVF vs VICI

DNVVF vs VICI: Dividend Comparison 2026

DNVVF yields 400.00% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DNVVF wins by $11436.84M in total portfolio value
10 years
DNVVF
DNVVF
● Live price
400.00%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11437.82M
Annual income
$7,667,192,697.76
Full DNVVF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — DNVVF vs VICI

📍 DNVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDNVVFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DNVVF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DNVVF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DNVVF
Annual income on $10K today (after 15% tax)
$34,000.00/yr
After 10yr DRIP, annual income (after tax)
$6,517,113,793.10/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, DNVVF beats the other by $6,516,584,020.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DNVVF + VICI for your $10,000?

DNVVF: 50%VICI: 50%
100% VICI50/50100% DNVVF
Portfolio after 10yr
$5719.41M
Annual income
$3,833,907,979.54/yr
Blended yield
67.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

DNVVF
No analyst data
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DNVVF buys
0
VICI buys
0
No recent congressional trades found for DNVVF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDNVVFVICI
Forward yield400.00%6.57%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$11437.82M$988.8K
Annual income after 10y$7,667,192,697.76$623,261.32
Total dividends collected$11090.87M$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DNVVF vs VICI ($10,000, DRIP)

YearDNVVF PortfolioDNVVF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$50,700$40,000.00$11,368$948.43+$39.3KDNVVF
2$243,782$189,532.71$13,339$1,493.16+$230.4KDNVVF
3$1,112,560$851,713.55$16,326$2,426.21+$1.10MDNVVF
4$4,823,161$3,632,721.39$21,123$4,112.15+$4.80MDNVVF
5$19,879,046$14,718,264.42$29,379$7,368.23+$19.85MDNVVF
6$77,964,520$56,693,940.88$44,804$14,191.64+$77.92MDNVVF
7$291,226,244$207,804,207.46$76,658$29,972.12+$291.15MDNVVF
8$1,037,056,355$725,444,273.70$150,894$71,015.81+$1036.91MDNVVF
9$3,523,955,262$2,414,304,962.28$350,814$193,582.47+$3523.60MDNVVF
10$11,437,824,828$7,667,192,697.76$988,809$623,261.32+$11436.84MDNVVF

DNVVF vs VICI: Complete Analysis 2026

DNVVFStock

DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.

Full DNVVF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this DNVVF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DNVVF vs SCHDDNVVF vs JEPIDNVVF vs ODNVVF vs KODNVVF vs MAINDNVVF vs NNNDNVVF vs EPRTDNVVF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.